What is GoodBelly Probiotics?
GoodBelly Probiotics operates at the intersection of functional nutrition and consumer packaged goods, offering a diverse suite of gut-friendly products including juice drinks, wellness shots, and specialized supplements. By prioritizing clean-label ingredients—such as prebiotic fiber and organic components—the company effectively serves the growing demographic of health-conscious consumers seeking dairy-free, gluten-free, and plant-based alternatives. Their market position is defined by a commitment to accessibility, ensuring that digestive health solutions are integrated into the daily routines of a broad consumer base. Through strategic product development and a focus on wellness-oriented retail channels, GoodBelly has established itself as a key player in the probiotics industry, leveraging scientific formulation to drive brand loyalty and repeat purchase behavior.
How much funding has GoodBelly Probiotics raised?
GoodBelly Probiotics has raised a total of $20.2M across 2 funding rounds:
Unspecified
$8.2M
Unspecified
$12M
Unspecified (2013): $8.2M with participation from Maveron LLC
Unspecified (2018): $12M led by Emil Capital Partners and 301
Key Investors in GoodBelly Probiotics
Maveron LLC
Maveron is a consumer-only venture capital firm that partners with innovative entrepreneurs to transform consumer experiences and industries, focusing on early-stage brands that prioritize human behavior.
Emil Capital Partners
ECP Growth is a strategic partner focused on unlocking the full potential of consumer brands through expertise and resources tailored to meet the needs of tomorrow's consumers.
301
301 Inc. is a venture capital company specializing in financial sectors, formed in 2012 and headquartered in Minneapolis, Minnesota.
What's next for GoodBelly Probiotics?
With the recent capital deployment, GoodBelly Probiotics is expected to focus on scaling its distribution networks and enhancing its R&D capabilities to maintain its competitive edge. The strategic roadmap likely involves expanding its footprint in major retail outlets and potentially diversifying its product line to address emerging trends in cognitive health and personalized nutrition. As the company transitions into this next phase of growth, the focus will remain on operational efficiency and brand equity, ensuring that its core mission of promoting digestive wellness remains central to its long-term commercial strategy. Investors will be monitoring the company's ability to leverage this latest financing to capture additional market share in the rapidly evolving functional food sector.
See full GoodBelly Probiotics company page
